OAR@UM: Browsing OAR@UM

Browsing by Subject Schizophrenia

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:

Showing results 33 to 52 of 55 < previous next >

Issue Date	Title	Author(s)
2016	Lack of association between dopaminergic antagonism and negative symptoms in schizophrenia : a positron emission tomography dopamine D2/3 receptor occupancy study	Fervaha, Gagan; Caravaggio, Fernando; Mamo, David; Mulsant, Benoit H.; Pollock, Bruce G.; Nakajima, Shinichiro; Gerretsen, Philip; Rajji, Tarek K.; Mar, Wanna; Iwata, Yusuke; Plitman, Eric; Chung, Jun Ku; Remington, Gary; Graff-Guerrero, Ariel
2014	The lived experience of professionals who work with patients diagnosed with schizophrenia : a quantitative study	Zerafa, Christiana
2009	Long-term stability of measuring D 2 receptors in schizophrenia patients treated with antipsychotics	Uchida, Hiroyuki; Graff-Guerrero, Ariel; Mulsant, Benoit H.; Pollock, Bruce G.; Mamo, David
2007	Managing suicidality in schizophrenia	Mamo, David
2022	Mental health literacy and attitudes towards schizophrenia and depression among University of Malta students	Cumbo, Kelly (2022)
2019	The other face of oxytocin : role of oxytocin in neuropsychiatric disorders	Chetcuti, Sarah; Sammut, Enya; Sammut, Melissa; Calleja-Agius, Jean
1970	The palmar anhidrotic response in chronic schizophrenia	Orr, Michael
2015	Parametric and non-parametric estimation methods for latent variables	Sheikh, Imran (2015)
2004	A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone	Mamo, David; Kapur, Shitij; Shammi, Chekkera M.; Papatheodorou, George; Mann, Steve; Therrien, Francois; Remington, Gary
2012	Predicting plasma concentration of risperidone associated with dosage change : a population pharmacokinetic study	Uchida, Hiroyuki; Mamo, David; Pollock, Bruce G.; Suzuki, Takefumi; Tsunoda, Kenichi; Watanabe, Koichiro; Mimura, Masaru; Bies, Robert R.
2009-03	Professor Basant K. Puri's Medical School talk : part 2 : fatty acids, depression, schizophrenia and Huntington's disease	Cilia-Vincenti, Albert
2021	Psychiatrists’ perceptions of schizophrenia and its recovery : a thematic analysis	Sargent, Janice; Abela, Angela
2007	Quantification of l-stepholidine in rat brain and plasma by high performance liquid chromatography combined with fluorescence detection	Odontiadis, John; MacKenzie, Erin M.; Natesan, Sridhar; Mamo, David; Kapur, Shitij; Baker, Glen B.
2009	The relationship between subjective well-being and dopamine D2 receptors in patients treated with a dopamine partial agonist and full antagonist antipsychotics	Mizrahi, Romina; Mamo, David; Rusjan, Pablo; Graff, Ariel; Houle, Sylvain; Kapur, Shitij
2000	SB 242084 : a selective serotonin 5-HT2c receptor antagonist	Di Matteo, Vincenzo; Di Giovanni, Giuseppe; Esposito, Ennio
2010	Sensitivity to antipsychotic drugs in older adults	Leon, Chloe; Gerretsen, Philip; Uchida, Hiroyuki; Suzuki, Takefumi; Rajji, Tarek K.; Mamo, David
2007	Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response - a double-blind PET study in schizophrenia	Agid, Ofer; Mamo, David; Ginovart, Nathalie; Vitcu, Irina; Wilson, Alan A.; Zipursky, Robert B.; Kapur, Shitij
2017	TCB-2 [(7R)-3-bromo-2, 5-dimethoxy-bicyclo[4.2.0]octa-1,3,5-trien-7- yl]methanamine] : a hallucinogenic drug, a selective 5-HT2A receptor pharmacological tool, or none of the above?	Di Giovanni, Giuseppe; De Deurwaerdère, Philippe
2011	Transient insight induction with electroconvulsive therapy in a patient with refractory schizophrenia : a case report and systematic literature review	Gerretsen, Philip; Diaz, Pablo; Mamo, David; Kavanagh, Doug; Menon, Mahesh; Pollock, Bruce G.; Graff-Guerrero, Ariel
2017	Treating negative symptoms of schizophrenia : antipsychotics vs. antidepressants and antipsychotics	Saliba, Alexei Silvan

Showing results 33 to 52 of 55 < previous next >